Pharmafile Logo
Pharmafocus logo
Advanced Search
Pradaxa image

NICE recommends new indication for troubled Pradaxa

October 31, 2014
Sales and Marketing Boehringer, NHS, NICE, Pradaxa, dabigatran, ingelheim, warfarin

NICE has recommended Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa for treating and preventing potentially-fatal blood clots in the legs …

News
BMS image

BMS lung cancer drug scores in Phase II

October 31, 2014
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, NSCLC, bristol myers-squibb, odivo

Bristol-Myers Squibb is still in the hunt to gain significant market share in the PD-1 therapeutic vaccine race after releasing …

News
Caner image

More cancer patients surviving for longer

October 31, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …

News
steven_castillo

Carmago hires drug development head

October 31, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carmago, steven castillo

US drug development firm Camargo Pharmaceutical Services has expanded its leadership team with the appointment of Steven Castillo as vice …

Appointment
Microsoft Band image

Microsoft enters into wearables market

October 30, 2014
Medical Communications, Sales and Marketing Apple, Microsoft, band, fitness, health, watch, wearable, wearables

Microsoft has launched a new wearable heath tracking device as it looks to battle with Apple and Samsung in an …

News
richard_ransohr

Two neuroscientists join Biogen Idec

October 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, richard ransohoff

Christopher Henderson and Richard Ransohoff have joined Biogen Idec to lead the company’s neurology research and discovery efforts. Henderson joins …

Appointment
Actos image

Takeda and Lilly get Actos trial reprieve

October 29, 2014
Sales and Marketing Actos, Takeda, bladder cancer, diabetes, lilly

A judge has dramatically reduced the $9 billion damages bill Takeda and Lilly were set to pay over safety allegations …

News
Sovaldi image

Sovaldi misses estimates but still makes history

October 29, 2014
Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi

The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …

News
sanofi_chris_viehbacher_2

Sanofi’s chief executive ousted

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Christopher Viehbacher, Sanofi

Sanofi’s chief executive Chris Viehbacher has been ejected from his role after the French firm’s board lost patience with his …

News
Google image

Google X developing diagnosis pill

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …

News
nhs_parliament_2_8

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

News
alison_doering

Quantum promotes senior head

October 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alison Doering, quantam pharmaceutical

Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical.  Doering will …

Appointment

PrimeVigilance Limited upgrades its validated databases for pharmacovigilance and medical information – ARISg™ and agInquirer™.

October 28, 2014

PrimeVigilance Limited, a pharmaceutical service provider for Pharmacovigilance and Medical Information operations today announced the completion of a major upgrade …

News
Press release
Merck image

Merck revenue falls

October 28, 2014
Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi

Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …

News
peter_finan

Karus Therapeutics appoints two heads

October 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Peter Finan, Simon Roitt, karus

UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …

Appointment
Celgene image

Celgene expands immunotherapy pipeline with Sutro

October 27, 2014
Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro

Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …

News
AZ image

AZ oncology drug a ‘Phoenix from the flames’

October 27, 2014
Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology

As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …

News

Scenesse recommended for rare sun disease in Europe

October 27, 2014
Sales and Marketing CHMP, Clinuvel Pharmaceuticals, EMA, EU, scenesse

The European Medicines Agency is recommending that Scenesse (afamelanotide) be approved for the prevention of severe sun burn in adults …

News

France Focus: Power without responsibility?

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …

Feature
perez

Cubist Pharmaceuticals names chief executive

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez

US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …

Appointment
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026